Chemotherapy targets cancer cells by disrupting DNA replication and mitotic processes, despite side effects on healthy cells.

EGFR tyrosine kinase inhibitors (TKIs) are effective treatments for EGFR-mutant non-small cell lung cancer (NSCLC). However, ...

The POLAR genomic signature can help predict the patients with early breast cancer who may benefit from adjuvant radiotherapy ...

These preclinical findings could lead ... Single-Dose Gene Therapy Is Potentially Life-Changing for Adults With Hemophilia B Sep. 25, 2024 — Adults with hemophilia B saw their number of bleeding ...

Radiation therapy (RT) is a cornerstone in cancer treatment, known for its ability to induce tumor cell death and modulate ...

Yanghee Woo, MD, provides an overview of the CROSS trial which focused on treating patients with gastroesophageal junction ...

Brooke began taking OGSIVEO on December 30, 2023, just a month after it was approved by the FDA for adults with progressing ...

Lung cancer is diagnosed by taking a biopsy from the suspicious area of the lung, which can be done with both bronchoscopy ...

Reducing the risk of metastatic relapse in patients with resectable soft tissue sarcomas is crucial for improving outcomes, because metastasis is the primary cause of mortality in this population.

CAR-T therapy leverages the body’s immune system to target and eliminate cancer cells ... it is possible to selectively ...

While stage 4 breast cancer is challenging, there are several effective treatment options available that can help manage the disease and improve quality of life.